The Cooper Companies, Inc. which can be found using ticker (COO) now have 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 560 and 280 calculating the average target price we see $376.92. Now with the previous closing price of $373.71 this now indicates there is a potential upside of .9%. It’s also worth noting that there is a 50 day moving average of $348.73 and the 200 day moving average is $317.77. The market capitalization for the company is $18,372m. Visit the company website at: https://www.coopercos.com
The potential market cap would be $18,530m based on the market consensus.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The company has a dividend yield of 0.02% with the ex dividend date set at 20-1-2023 (DMY).
Other points of data to note are a P/E ratio of 49.2, revenue per share of 68.55 and a 3% return on assets.
